roups). Genedata Biologics captures all relevant data, from the definition of the desired biomolecule’s blueprint to the final product, including all production process-relevant parameters (e.g. transfection protocols, cell culture and fermentation conditions, media, purification methods, and product titers and quality parameters). All data are traced back to the plasmids and cell lines and can be analyzed together. The system also integrates with upstream and downstream processes, and now comes with sample and inventory management that streamlines tracking of samples and aliquots.
The system provides easy-to-use, comprehensive, and automated data capture, processing and reporting capabilities. It minimizes duplication of work, eliminates error-prone manual activities, and provides extremely valuable transparency for efficient decision making, so that high-quality proteins can be delivered faster.
“Having successfully supported important workflows in biopharma discovery, we now set our sights on extending Genedata Biologics to biopharma development with an initial focus on cell line and bioprocess development,” said Dr. Othmar Pfannes, CEO of Genedata. “Our innovative platform aids in the rapid and systematic development of optimized bioprocesses, and specifically helps to standardize and streamline cell line development. This brings us another step closer in providing our customers with a fully integrated platform that supports the complete biopharmaceutical R&D process.”
ESACT Editorial Note: June 24 and 25 from 12:30 – 14:30 CEST, Genedata Biologics will present the following posters: “Genedata Biologics - An Integrated Data Management Platform for Biopharmaceutical R&D” and “Biologics Expression System Optimization and Bioprocess Development.” To schedule a briefing contact jackie.thrasivoulos(at)genedata(dot)com.
Genedata transforms data into intelligence with a portfolio of advanced software solutio
Page: 1 2 3 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS2
. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization3
. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS4
. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 20135
. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer6
. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit7
. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry8
. Genedata Biologics 3.0 Boosts Efficiency Through Standardization9
. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas10
. Genedata Screener for HCS Advances Phenotypic Screening11
. Genedata Expressionist® Established as Data Analysis Platform for Oncological Research